Chk2 and REGγ-dependent DBC1 regulation in DNA damage induced apoptosis

Nucleic Acids Research

Volumn 42, Issue 21, 2014, Pages 13150-13160

  Magni, Martina ^a   Ruscica, Vincenzo ^a   Buscemi, Giacomo ^b   Kim, Ja Eun ^c   Nachimuthu, Benjamin Tamilselvan ^d   Fontanella, Enrico ^a   Delia, Domenico ^a   Zannini, Laura ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c Kyung Hee University Hospital   (South Korea)

^d CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CHECKPOINT KINASE 2; KI ANTIGEN; KIAA1967 PROTEIN, HUMAN; PROTEASOME; SIGNAL TRANSDUCING ADAPTOR PROTEIN; SIRTUIN 1;

ANTAGONISTS AND INHIBITORS; APOPTOSIS; DNA DAMAGE; HUMAN; METABOLISM; TUMOR CELL LINE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; APOPTOSIS; AUTOANTIGENS; CELL LINE, TUMOR; CHECKPOINT KINASE 2; DNA DAMAGE; HUMANS; PROTEASOME ENDOPEPTIDASE COMPLEX; SIRTUIN 1;

EID: 84941046842     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gku1065     Document Type: Article

References (45)

1. Ciccia, A. And Elledge, S. J. (2010) The DNA damage response: making it safe to play with knives. Mol. Cell, 40, 179-204.
2. Shiloh, Y. And Ziv, Y. (2013) The ATM protein kinase: regulating the cellular response to genotoxic stress, and more. Nat. Rev. Mol. Cell Biol., 14, 197-210.
3. Stracker, T. H., Usui, T. And Petrini, J. H. (2009) Taking the time to make important decisions: The checkpoint effector kinases Chk1 and Chk2 and the DNA damage response. DNA Repair (Amst.), 8, 1047-1054.
4. Buscemi, G., Zannini, L., Fontanella, E., Lecis, D., Lisanti, S. And Delia, D. (2009) The shelterin protein TRF2 inhibits Chk2 activity at telomeres in the absence of DNA damage. Curr. Biol., 19, 874-879.
5. Hu, C., Zhang, S., Gao, X., Gao, X., Xu, X., Lv, Y., Zhang, Y., Zhu, Z., Zhang, C., Li, Q. et al. (2012) Roles of kruppel-associated box (KRAB)-associated co-repressor KAP1 ser-473 phosphorylation in DNA damage response. J. Biol. Chem., 287, 18937-18952.
6. Bolderson, E., Savage, K. I., Mahen, R., Pisupati, V., Graham, M. E., Richard, D. J., Robinson, P. J., Venkitaraman, A. R. And Khanna, K. K. (2012) Kruppel-associated box (KRAB)-associated co-repressor (KAP-1) ser-473 phosphorylation regulates heterochromatin protein 1beta (HP1-beta) mobilization and DNA repair in heterochromatin. J. Biol. Chem., 287, 28122-28131.
7. Stolz, A., Ertych, N. And Bastians, H. (2011) Tumor suppressor CHK2: regulator of DNA damage response and mediator of chromosomal stability. Clin. Cancer Res., 17, 401-405.
8. Mao, I., Liu, J., Li, X. And Luo, H. (2008) REGgamma, a proteasome activator and beyond? Cell Mol. Life Sci., 65, 3971-3980.
9. Zannini, L., Lecis, D., Buscemi, G., Carlessi, L., Gasparini, P., Fontanella, E., Lisanti, S., Barton, L. And Delia, D. (2008) REGgamma proteasome activator is involved in the maintenance of chromosomal stability. Cell. Cycle, 7, 504-512.
10. Liu, J., Wang, Y., Li, L., Zhou, L., Wei, H., Zhou, Q., Liu, J., Wang, W., Ji, L., Shan, P. et al. (2013) Site-specific acetylation of the proteasome activator REGgamma directs its heptameric structure and functions. J. Biol. Chem., 288, 16567-16578.
11. Dong, S., Jia, C., Zhang, S., Fan, G., Li, Y., Shan, P., Sun, L., Xiao, W., Li, L., Zheng, Y. et al. (2013) The REGgamma proteasome regulates hepatic lipid metabolism through inhibition of autophagy. Cell. Metab., 18, 380-391.
12. Zannini, L., Buscemi, G., Fontanella, E., Lisanti, S. And Delia, D. (2009) REGgamma/PA28gamma proteasome activator interacts with PML and Chk2 and affects PML nuclear bodies number. Cell. Cycle, 8, 2399-2407.
13. Levy-Barda, A., Lerenthal, Y., Davis, A. J., Chung, Y. M., Essers, J., Shao, Z., van Vliet, N., Chen, D. J., Hu, M. C., Kanaar, R. et al. (2011) Involvement of the nuclear proteasome activator PA28gamma in the cellular response to DNA double-strand breaks. Cell. Cycle, 10, 4300-4310.
14. Hamaguchi, M., Meth, J. L., von Klitzing, C., Wei, W., Esposito, D., Rodgers, L., Walsh, T., Welcsh, P., King, M. C. And Wigler, M. H. (2002) DBC2, a candidate for a tumor suppressor gene involved in breast cancer. Proc. Natl. Acad. Sci. U. S. A., 99, 13647-13652.
15. Joshi, P., Quach, O. L., Giguere, S. S. And Cristea, I. M. (2013) A functional proteomics perspective of DBC1 as a regulator of transcription. J. Proteomics Bioinform., (Suppl. 2), 002.
16. Chini, E. N., Chini, C. C., Nin, V. And Escande, C. (2013) Deleted in breast cancer-1 (DBC-1) in the interface between metabolism, aging and cancer. Biosci. Rep., 33, doi:10. 1042/BSR20130062.
17. Sung, J. Y., Kim, R., Kim, J. E. And Lee, J. (2010) Balance between SIRT1 and DBC1 expression is lost in breast cancer. Cancer. Sci., 101, 1738-1744.
18. Lee, H., Kim, K. R., Noh, S. J., Park, H. S., Kwon, K. S., Park, B. H., Jung, S. H., Youn, H. J., Lee, B. K., Chung, M. J. et al. (2011) Expression of DBC1 and SIRT1 is associated with poor prognosis for breast carcinoma. Hum. Pathol., 42, 204-213.
19. Kim, S. H., Kim, J. H., Yu, E. J., Lee, K. W. And Park, C. K. (2012) The overexpression of DBC1 in esophageal squamous cell carcinoma correlates with poor prognosis. Histol. Histopathol., 27, 49-58.
20. Cha, E. J., Noh, S. J., Kwon, K. S., Kim, C. Y., Park, B. H., Park, H. S., Lee, H., Chung, M. J., Kang, M. J., Lee, D. G. et al. (2009) Expression of DBC1 and SIRT1 is associated with poor prognosis of gastric carcinoma. Clin. Cancer Res., 15, 4453-4459.
21. Zhang, Y., Gu, Y., Sha, S., Kong, X., Zhu, H., Xu, B., Li, Y. And Wu, K. (2014) DBC1 is over-expressed and associated with poor prognosis in colorectal cancer. Int. J. Clin. Oncol., 19, 106-112.
22. Trauernicht, A. M., Kim, S. J., Kim, N. H., Clarke, R. And Boyer, T. G. (2010) DBC-1 mediates endocrine resistant breast cancer cell survival. Cell. Cycle, 9, 1218-1219.
23. Trauernicht, A. M., Kim, S. J., Kim, N. H. And Boyer, T. G. (2007) Modulation of estrogen receptor alpha protein level and survival function by DBC-1. Mol. Endocrinol., 21, 1526-1536.
24. Kim, J. E., Chen, J. And Lou, Z. (2008) DBC1 is a negative regulator of SIRT1. Nature, 451, 583-586.
25. Zhao, W., Kruse, J. P., Tang, Y., Jung, S. Y., Qin, J. And Gu, W. (2008) Negative regulation of the deacetylase SIRT1 by DBC1. Nature, 451, 587-590.
26. Vaquero, A., Scher, M., Lee, D., Erdjument-Bromage, H., Tempst, P. And Reinberg, D. (2004) Human SirT1 interacts with histone H1 and promotes formation of facultative heterochromatin. Mol. Cell, 16, 93-105.
27. Vaziri, H., Dessain, S. K., Ng Eaton, E., Imai, S. I., Frye, R. A., Pandita, T. K., Guarente, L. And Weinberg, R. A. (2001) hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell, 107, 149-159.
28. Zannini, L., Buscemi, G., Kim, J. E., Fontanella, E. And Delia, D. (2012) DBC1 phosphorylation by ATM/ATR inhibits SIRT1 deacetylase in response to DNA damage. J. Mol. Cell. Biol., 4, 294-303.
29. Yuan, J., Luo, K., Liu, T. And Lou, Z. (2012) Regulation of SIRT1 activity by genotoxic stress. Genes Dev., 26, 791-796.
30. Zhang, H., Xu, Y., Filipovic, A., Lit, L. C., Koo, C. Y., Stebbing, J. And Giamas, G. (2013) SILAC-based phosphoproteomics reveals an inhibitory role of KSR1 in p53 transcriptional activity via modulation of DBC1. Br. J. Cancer, 109, 2675-2684.
31. Zheng, H., Yang, L., Peng, L., Izumi, V., Koomen, J., Seto, E. And Chen, J. (2013) hMOF acetylation of DBC1/CCAR2 prevents binding and inhibition of SirT1. Mol. Cell. Biol., 33, 4960-4970.
32. Zannini, L., Lecis, D., Lisanti, S., Benetti, R., Buscemi, G., Schneider, C. And Delia, D. (2003) Karyopherin-alpha2 protein interacts with Chk2 and contributes to its nuclear import. J. Biol. Chem., 278, 42346-42351.
33. Buscemi, G., Perego, P., Carenini, N., Nakanishi, M., Chessa, L., Chen, J., Khanna, K. And Delia, D. (2004) Activation of ATM and Chk2 kinases in relation to the amount of DNA strand breaks. Oncogene, 23, 7691-7700.
34. Abdelmohsen, K., Pullmann, R. Jr, Lal, A., Kim, H. H., Galban, S., Yang, X., Blethrow, J. D., Walker, M., Shubert, J., Gillespie, D. A. et al. (2007) Phosphorylation of HuR by Chk2 regulates SIRT1 expression. Mol. Cell, 25, 543-557.
35. Chen, C. R., Wang, W., Rogoff, H. A., Li, X., Mang, W. And Li, C. J. (2005) Dual induction of apoptosis and senescence in cancer cells by Chk2 activation: checkpoint activation as a strategy against cancer. Cancer Res., 65, 6017-6021.
36. Buscemi, G., Carlessi, L., Zannini, L., Lisanti, S., Fontanella, E., Canevari, S. And Delia, D. (2006) DNA damage-induced cell cycle regulation and function of novel Chk2 phosphoresidues. Mol. Cell. Biol., 26, 7832-7845.
37. Carlessi, L., Buscemi, G., Larson, G., Hong, Z., Wu, J. Z. And Delia, D. (2007) Biochemical and cellular characterization of VRX0466617, a novel and selective inhibitor for the checkpoint kinase Chk2. Mol. Cancer. Ther., 6, 935-944.
38. Carlessi, L., Buscemi, G., Fontanella, E. And Delia, D. (2010) A protein phosphatase feedback mechanism regulates the basal phosphorylation of Chk2 kinase in the absence of DNA damage. Biochim. Biophys. Acta, 1803, 1213-1223.
39. Schwarz, J. K., Lovly, C. M. And Piwnica-Worms, H. (2003) Regulation of the Chk2 protein kinase by oligomerization-mediated cis-and trans-phosphorylation. Mol. Cancer. Res., 1, 598-609.
40. Buscemi, G., Ricci, C., Zannini, L., Fontanella, E., Plevani, P. And Delia, D. (2014) Bimodal regulation of p21waf1 protein as function of DNA damage levels. Cell Cycle, 13, 2901-2912.
41. Zhang, D., Zaugg, K., Mak, T. W. And Elledge, S. J. (2006) A role for the deubiquitinating enzyme USP28 in control of the DNA-damage response. Cell, 126, 529-542.
42. Alaoui-El-Azher, M., Mans, J. J., Baker, H. V., Chen, C., Progulske-Fox, A., Lamont, R. J. And Handfield, M. (2010) Role of the ATM-checkpoint kinase 2 pathway in CDT-mediated apoptosis of gingival epithelial cells. PLoS One, 5, e11714.
43. Kim, W. And Kim, J. E. (2013) Deleted in breast cancer 1 (DBC1) deficiency results in apoptosis of breast cancer cells through impaired responses to UV-induced DNA damage. Cancer Lett., 333, 180-186.
44. Kim, W., Jeong, J. W. And Kim, J. E. (2014) CCAR2 deficiency augments genotoxic stress-induced apoptosis in the presence of melatonin in non-small cell lung cancer cells. Tumour Biol.
45. Park, S. H., Riley, P. 4th and Frisch, S. M. (2013) Regulation of anoikis by deleted in breast cancer-1 (DBC1) through NF-kappaB. Apoptosis, 18, 949-962.